---
title: "SL Science 盘后跌近 11%，2025 财年亏损扩大至 382 万美元"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291593586.md"
description: "SLBT.US 盘后跌 10.52%，现报 5.36 美元。5 日累涨超 21%，2025 财年营收同比下降 35%。"
datetime: "2026-07-02T21:51:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291593586.md)
  - [en](https://longbridge.com/en/news/291593586.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291593586.md)
generator: "portal-rs"
---

# SL Science 盘后跌近 11%，2025 财年亏损扩大至 382 万美元

SL Science(SLBT.US) 盘后跌**10.52%**，现报**5.36**美元。

消息面上，公司 2025 财年净亏损扩大至**382**万美元，营收同比下降**35%**至**220**万美元。该股近 5 日累计涨幅超**21%**。

### Related Stocks

- [SLBT.US](https://longbridge.com/en/quote/SLBT.US.md)

## Related News & Research

- [SL Science Seeks FDA Orphan Drug Status for Gamma Delta T Cell Therapy in Glioblastoma](https://longbridge.com/en/news/292326758.md)
- [SL Science Holding files Form 3 as CEO Ching-Dong Wang reports 333,832,129 shares beneficially owned](https://longbridge.com/en/news/290244372.md)
- [SL Science FY25 net loss widens to USD 3.82 million; revenue falls 35% to USD 2.2 million](https://longbridge.com/en/news/290247592.md)
- [SL Science Holding Limited Reports Full Year 2025 Financial Results | SLBT Stock News](https://longbridge.com/en/news/290247925.md)
- [Ching-Dong Wang Discloses Investment at SL Science Holding Ltd with 59.53% Stake](https://longbridge.com/en/news/290245423.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**